Effects of conventional ultrafiltration on renal performance during adult cardiopulmonary bypass procedures

Journal of Extra-Corporeal Technology

Volumn 38, Issue 2, 2006, Pages 144-153

  Kuntz, Rick A ^a,c   Holt, David W ^b   Turner, Scott ^a   Stichka, Lee ^a   Thacker, Bryan ^a  

^a Bay Medical Center Panama City   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CETECH Inc   (United States)

Author keywords

Bypass urine; Conventional ultrafiltration; Extracorporeal; Fluid balance; Hematocrit; Hemodilution; Renal failure; Urine output

Indexed keywords

CREATININE;

ADULT; AGED; ANESTHESIA; ARTICLE; BLOOD PRESSURE; CAPILLARY LEAK SYNDROME; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DEMOGRAPHY; EXTRACORPOREAL CIRCULATION; FEMALE; FLUID BALANCE; HEMATOCRIT; HEMOCONCENTRATION; HEMODILUTION; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; MALE; PATIENT SELECTION; PERFUSION PRESSURE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; ULTRAFILTRATION; URINE VOLUME; KIDNEY; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY;

AGED; CARDIOPULMONARY BYPASS; EXTRACORPOREAL CIRCULATION; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ULTRAFILTRATION;

EID: 33749046343     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Tassani P, Schad H, Winkler C, et al. Capillary leak syndrome after cardiopulmonary bypass in elective, uncomplicated coronary artery bypass grafting operations: Does it exist? J Thorac Cardiovasc Surg. 2002;123:735-41.
2. Sever K, Tansel SK, Basaran M, et al. The benefits of continuous ultrafiltration in pediatric cardiac surgery. Scan Cardiovasc J. 2004;38:307-11.
3. Hamada Y, Kawachi K, Tsunooka N, et al. Capillary leakage in cardiac surgery with cardiopulmonary bypass. Asian Cardiovasc Thorac Ann. 2004;12:193-7.
4. Zhang S, Wang S, Yao S. Evidence for development of capillary leak syndrome associated with cardiopulmonary bypass in pediatric patients with homozygous C4A null phenotype. Anesthesiology. 2004;100:1387-93.
5. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg. 2001;71:745-54.
6. Gray DT, Veenstra DL. Comparative economic analyses of minimally invasive direct coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2003;125:618-24.
7. Stauder NI, Fenchel M, Stauder H, et al. Assessment of minimally invasive direct coronary artery bypass grafting of the left internal thoracic artery by means of magnetic resonance imaging. J Thorac Cardiovasc Surg. 2005;129:607-14.
8. Izutani H, Gill IS. Acute graft failure caused by an intracoronary shunt in minimally invasive direct coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:723-4.
9. Zimarino M, Gallina S, Di Fulvio M, et al. Intraoperative ischemia and long-term events after minimally invasive coronary surgery. Ann Thorac Surg. 2004;78:135-41.
10. Remadi JP, Marticho P, Butoi I, et al. Clinical experience with miniextracorporeal circulation system: an evolution or a revolution? Ann Thorac Surg. 2004;77:2172-5.
11. Remadi JP, Rakotoarivello P, Marticho P, et al. Aortic valve replacement with the minimal extracorporeal circulation (Jostra MECC System) versus standard cardiopulmonary bypass: A randomized prospective trial. J Thorac Cardiovasc Surg. 2004;128:436-41.
12. Eising GP, Pfauder M, Niemeyer M, et al. Retrograde autologous priming: is it useful in elective on-pump coronary artery bypass surgery? Ann Thorac Surg. 2003;75:23-7.
13. Baufreton C, Brux J, Binuani P, et al. A combined approach for improving cardiopulmonary bypass in coronary artery surgery: A pilot study. Perfusion. 2002;17:407-13.
14. Banbury MK, White JA, Blackstone EH, et al. Vacuum-assisted venous return reduces blood usage. J Thorac Cardiovasc Surg. 2003;126:680-87.
15. Munster K, Andersen U, Mikkelsen J, Pettersson G. Vacuum assisted venous drainage (VAVD). Perfusion. 1999;14:419-23.
16. Kurusz M, Butler B. Bubbles and bypass: an update. Perfusion. 2004;19:S49-55.
17. Tallman RD, Dumond M, Brown D. Inflammatory mediator removal by zero balance ultrafiltration during cardiopulmonary bypass. Perfusion. 2002;17:111-5.
18. de Baar M, Diephuis JC, Moons KG, et al. The effect of zero-balanced ultra_filtration during cardiopulmonary bypass onS100b release and cognitive function. Perfusion. 2003;18:9-14.
19. Wang W, Huang HM, Zhu DM, et al. Modified ultrafiltration in paediatric cardiopulmonary bypass. Perfusion. 1998;13:304-10.
20. Bando K, Turrentine W, Vijay P, et al. Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease. Ann Thorac Surg. 1998;66:821-7.
21. Friesen RH, Campbell DN, Clarke DR, Tornabene MA. Modified ultrafiltration attenuates dilutional coagulopathy in pediatric open heart operations. Ann Thorac Surg. 1997;64:1787-9.
22. Ungerleider RM. Effects of cardiopulmonary bypass and use of modified ultrafiltration. Ann Thorac Surg. 1998;65:S35-9.
23. Kiziltepe U, Uysalel A, Corapcioglu T, et al. Effects of combined conventional and modified ultrafiltration in adult patients. Ann Thorac Surg. 2001;71:684-93.
24. Babka R, Petress J, Briggs R, et al. Conventional haemofiltration during routine coronary bypass surgery. Perfusion. 1997;12:187-92.
25. Thompson LD, McElhinney DB, Findlay P, et al. A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2001;122:220-8.
26. Daggett CW, Lodge AJ, Scarborough JE, et al. Modified Ultrafiltration versus conventional ultrafiltration: a randomized prospective study. J Thorac Cardiovasc Surg. 1998;115:341-2.
27. Chew M. Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass? Perfusion. 2004;19:S57-60.
28. Chew R, Brix-Christensen V. Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: A prospective, randomized study. Perfusion. 2002;17:327-33.
29. Wand M, Chiu I. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Soc Thorac Surg. 1996;61:651-6.
30. Shimpo H, Shimamoto A, Sawamura Y, et al. Ultrafiltration of the priming blood before cardiopulmonary bypass attenuated inflammatory response and improves postoperative clinical course in pediatric patients. Shock. 2001;1(suppl 16):51-4.
31. Journois D, Pouard P, Greeley WJ, et al. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components. Anesthesiology. 1994;81:1181-9.
32. Hoffmann JN, Hartl WH, Deppisch R, et al. Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxin and cytokines in human sepsis. Intensive Med. 1996;22:1360-7.
33. Chertow GM, Levy EM, Hammermeister KE, et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343-8.
34. Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation: prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994;107:1489-95.
35. Provenchere S, Plantefeve G, Hufnagel G, et al. Renal dysfunction after cardiac surgery with normothermic cardiopulmonary bypass: Incidence, risk factor, and effect on clinical outcome. Anesth Analg. 2003;96:1258-64.
36. Ostermann ME, Taube D, Morgan CJ, Evans TW. Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Med. 2000;26:565-71.
37. Corwin HL, Sprague SM, DeLaria GA, Norusis MJ. Acute renal failure associated with cardiac operations. A case-control study. J Thorac Cardiovasc Surg. 1989;98:1107-12.
38. Waloth BH, Albetini B. Ultrafiltration in cardiac surgery. J Extra Corpor Technol. 1984;16:68-72.
39. Huang H, Yao T, Wang W, et al. Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg. 2003;76:136-40.
40. Nagashima M, Shin'oka T, Nollert G, et al. High-volume continuous hemofiltration during cardiopulmonary bypass attenuates pulmonary dysfunction in neonatal lambs after deep hypothermic circulatory arrest. Circulation. 1998;98:378-84.
41. Kiziltepe U. Effects of combined conventional and modified ultrafiltration in adult patients. Ann Thorac Surg. 2001;71:684-93.
42. Portela F, Pensado A, Sanchez A, et al. A simple technique to perform combined ultrafiltration. Ann Thorac Surg. 1999;67:859-61.
43. Klineberg PL, Kam CA, Johnson DC, et al. Hematocrit and blood volume control during cardiopulmonary bypass with the use of hemofiltration. Anesthesiology. 1984;60:478-80.
44. Journois D, Israel-Biet D, Pouard P, et al. High-volume, zerobalanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology. 1996;85:965-76.
45. Wang MJ, Chiu IS, Hsu CM, et al. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg. 1996;61:651-6.
46. Onoe M, Magara T, Yamamoto Y, Nojima T. Modified ultrafiltration removes serum interleukin-8 in adult cardiac surgery. Perfusion. 2001;16:37-42.
47. Toraman F, Evrenkaya S, Yuce M, et al. Highly positive intraoperative fluid balance during cardiac surgery is associated with adverse outcome. Perfusion. 2004;19:85-91.
48. Koller ME, Bert J, Segadal L, Reed RK. Estimation of total body fluid shifts between plasma and interstitium in man during extracorporeal circulation. Acta Anaesthesiol Scand. 1992;36:255-59.
49. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
50. Vervoort G, Willems HL, Wetzels JF. Assessment of glomerular filtration rate in health subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant. 2002;17:1909-13.
51. Fournier A, Achard JM. Mnemotechnical note on the use of Cockcroft creatinine clearance formula for the validation of a 24-h urine collection. Nephrol Dial Transplant. 2000;15:1677-78.
52. Spinler SA, Nawarskas JJ, Boyce EG, et al. Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Ann Pharmacother. 1998;32:1275-83.
53. Weerasinghe A, Athanasiou T, Al-Ruzzeh S, et al. Functional renal outcome in on-pump and off-pump coronary revascularization: A propensity-based analysis. Ann Thorac Surg. 2005;79:1577-83.
54. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resources utilization. Ann Intern Med. 1998;128:194-203.
55. Pathi VL, Morrison J, MacPhaden A, et al. Alterations in renal microcirculation during cardiopulmonary bypass. Ann Thorac Surg. 1998;65:993-8.
56. Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994;107:1489-95.
57. Ascione R, Lloyd CT, Underwood MJ, et al. On-pump versus offpump coronary revascularization: evaluation of renal function. Ann Thorac Surg. 1999;68:493-8.
58. Gamoso MG, Phillips-Bute B, Landolfo KP, et al. Off-pump versus on-pump coronary artery bypass surgery and post-operative renal dysfunction. Anaesth Analg. 2000;91:1080-4.
59. Stallwood MI, Grayson AD, Mills K, Scawn ND. Acute Renal Failure in Coronary Artery Bypass Surgery: Independent Effect of Cardiopulmonary Bypass. Ann Thorac Surg. 2004;77:968-72.
60. Karkouti K, Beattie WS, Wijeysundera DN, et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005;129:391-400.
61. Yeboah ED, Petrie A, Pead JL. Acute renal failure and open heart surgery. BMJ. 1972;1:415-8.
62. Krian A. Incidence, prevention, and treatment of acute renal failure following cardiopulmonary bypass. Int Anesthesiol Clin. 1976;14:87-101.
63. Chen Y, Berglin E, Belboul A, Roberts D. A mathematical analysis of hemorheological changes during heart valve replacement. J Cardiovasc Surg (Torino). 2000;41:37-43.
64. Hellberg PO, Bayati A, Kallskog O, Wolgast M. Red cell trapping after ischemia and long-term kidney damage. Influence of hematocrit. Kidney Int. 1990;37:1240-7.
65. Defoe G, Ross C, Olmstead EM, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg. 2001;71:769-76.
66. Fang WC, Helm RE, Krieger KH, et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation. 1997;96(Suppl 2):194-9.
67. Swaminathan M, Phillips-Bute BG, Conlon PJ, et al. The association of lowest hematocrit durig cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg. 2003;76:784-92.
68. Habib RH, Zacharias A, Schwann TA, et al. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: Should current practice be changed? J Thorac Cardiovasc Surg. 2003;125:1438-50.
69. Ranucci M, Pavesi M, Mazza E, et al. Risk factors for renal dysfunction after coronary surgery: The role of cardiopulmonary bypass technique. Perfusion. 1994;9:319-26.